ArticleCase reports in pathology2026
Adenoid Cystic Carcinoma of the Male Breast: An Exceptionally Rare Presentation.
Article in Case reports in pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Adenoid Cystic Carcinoma of the Male Breast: An Exceptionally Rare Presentation.Case reports in pathology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Adenoid cystic carcinoma (ACC) of the breast is an exceedingly rare malignancy, accounting for less than 0.1% of all breast cancers. It typically affects postmenopausal women and is exceptionally uncommon in men, with fewer than 20 cases reported in the literature. Histologically, ACC is a biphasic tumor composed of epithelial and myoepithelial cells with distinct cribriform, tubular, and solid-basaloid subtypes. Awareness of this condition in men is essential to prevent misdiagnosis and guide appropriate management. Case Presentation: We report the case of a 40-year-old man who presented with a painful right breast mass that had been present for 3 years. Ultrasonography revealed multiple solid lesions, and histopathological examination following surgical excision confirmed ACC with cribriform and solid patterns. Immunohistochemistry results were negative for ER, PR, HER2, and p53, with a Ki-67 index of 17%. Although a chest CT scan revealed suspicious bilateral pulmonary nodules, FDG-PET/CT did not reveal evidence of distant metastasis. Subsequent total mastectomy after 3 months revealed cribriform ACC without lymph node involvement. Due to imaging findings suggestive of possible local recurrence or residual disease, the patient was treated with adjuvant radiotherapy. Conclusion: This case highlights the importance of considering ACC in the differential diagnosis of breast masses in male patients. Given the rarity of this tumor in males, accurate histopathological and immunohistochemical diagnoses are critical to avoid misclassification. Although the overall prognosis is favorable, close follow-up is warranted because of the potential for recurrence and metastases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.